315 related articles for article (PubMed ID: 25555392)
1. The SIX1-EYA transcriptional complex as a therapeutic target in cancer.
Blevins MA; Towers CG; Patrick AN; Zhao R; Ford HL
Expert Opin Ther Targets; 2015 Feb; 19(2):213-25. PubMed ID: 25555392
[TBL] [Abstract][Full Text] [Related]
2. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL
Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis.
Zhou H; Blevins MA; Hsu JY; Kong D; Galbraith MD; Goodspeed A; Culp-Hill R; Oliphant MUJ; Ramirez D; Zhang L; Trinidad-Pineiro J; Mathews Griner L; King R; Barnaeva E; Hu X; Southall NT; Ferrer M; Gustafson DL; Regan DP; D'Alessandro A; Costello JC; Patnaik S; Marugan J; Zhao R; Ford HL
Cancer Res; 2020 Jun; 80(12):2689-2702. PubMed ID: 32341035
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network.
Kingsbury TJ; Kim M; Civin CI
Adv Cancer Res; 2019; 141():1-42. PubMed ID: 30691681
[TBL] [Abstract][Full Text] [Related]
5. Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome.
Patrick AN; Cabrera JH; Smith AL; Chen XS; Ford HL; Zhao R
Nat Struct Mol Biol; 2013 Apr; 20(4):447-53. PubMed ID: 23435380
[TBL] [Abstract][Full Text] [Related]
6. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis.
Li X; Oghi KA; Zhang J; Krones A; Bush KT; Glass CK; Nigam SK; Aggarwal AK; Maas R; Rose DW; Rosenfeld MG
Nature; 2003 Nov; 426(6964):247-54. PubMed ID: 14628042
[TBL] [Abstract][Full Text] [Related]
7. Eya1 and Eya2 proteins are required for hypaxial somitic myogenesis in the mouse embryo.
Grifone R; Demignon J; Giordani J; Niro C; Souil E; Bertin F; Laclef C; Xu PX; Maire P
Dev Biol; 2007 Feb; 302(2):602-16. PubMed ID: 17098221
[TBL] [Abstract][Full Text] [Related]
8. Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activity.
Krueger AB; Dehdashti SJ; Southall N; Marugan JJ; Ferrer M; Li X; Ford HL; Zheng W; Zhao R
J Biomol Screen; 2013 Jan; 18(1):85-96. PubMed ID: 22820394
[TBL] [Abstract][Full Text] [Related]
9. The EYA-SO/SIX complex in development and disease.
Xu PX
Pediatr Nephrol; 2013 Jun; 28(6):843-54. PubMed ID: 22806561
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and functional characterization of six SIX1 Branchio-oto-renal syndrome mutations.
Patrick AN; Schiemann BJ; Yang K; Zhao R; Ford HL
J Biol Chem; 2009 Jul; 284(31):20781-90. PubMed ID: 19497856
[TBL] [Abstract][Full Text] [Related]
11. Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1.
Zou D; Silvius D; Davenport J; Grifone R; Maire P; Xu PX
Dev Biol; 2006 May; 293(2):499-512. PubMed ID: 16530750
[TBL] [Abstract][Full Text] [Related]
12. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.
Hughes CJ; Alderman C; Wolin AR; Fields KM; Zhao R; Ford HL
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189098. PubMed ID: 38555001
[TBL] [Abstract][Full Text] [Related]
13. Two naturally derived small molecules disrupt the sineoculis homeobox homolog 1-eyes absent homolog 1 (SIX1-EYA1) interaction to inhibit colorectal cancer cell growth.
Wu J; Huang B; He HB; Lu WZ; Wang WG; Liu H
Chin Med J (Engl); 2021 Sep; 134(19):2340-2352. PubMed ID: 34561318
[TBL] [Abstract][Full Text] [Related]
14. The DACH/EYA/SIX gene network and its role in tumor initiation and progression.
Liu Y; Han N; Zhou S; Zhou R; Yuan X; Xu H; Zhang C; Yin T; Wu K
Int J Cancer; 2016 Mar; 138(5):1067-75. PubMed ID: 26096807
[TBL] [Abstract][Full Text] [Related]
15. The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone.
Tadjuidje E; Wang TS; Pandey RN; Sumanas S; Lang RA; Hegde RS
PLoS One; 2012; 7(4):e34806. PubMed ID: 22545090
[TBL] [Abstract][Full Text] [Related]
16. The Eyes Absent Proteins: Unusual HAD Family Tyrosine Phosphatases.
Roychoudhury K; Hegde RS
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920226
[TBL] [Abstract][Full Text] [Related]
17. Branchio-oto-renal syndrome.
Kochhar A; Fischer SM; Kimberling WJ; Smith RJ
Am J Med Genet A; 2007 Jul; 143A(14):1671-8. PubMed ID: 17238186
[TBL] [Abstract][Full Text] [Related]
18. Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation.
Heanue TA; Reshef R; Davis RJ; Mardon G; Oliver G; Tomarev S; Lassar AB; Tabin CJ
Genes Dev; 1999 Dec; 13(24):3231-43. PubMed ID: 10617572
[TBL] [Abstract][Full Text] [Related]
19. Activation of Six1 target genes is required for sensory placode formation.
Christophorou NA; Bailey AP; Hanson S; Streit A
Dev Biol; 2009 Dec; 336(2):327-36. PubMed ID: 19781543
[TBL] [Abstract][Full Text] [Related]
20. Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.
Krueger AB; Drasin DJ; Lea WA; Patrick AN; Patnaik S; Backos DS; Matheson CJ; Hu X; Barnaeva E; Holliday MJ; Blevins MA; Robin TP; Eisenmesser EZ; Ferrer M; Simeonov A; Southall N; Reigan P; Marugan J; Ford HL; Zhao R
J Biol Chem; 2014 Jun; 289(23):16349-61. PubMed ID: 24755226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
